DEL ROSSO, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 9.851
EU - Europa 6.656
AS - Asia 2.123
SA - Sud America 249
OC - Oceania 103
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 6
Totale 19.044
Nazione #
US - Stati Uniti d'America 9.815
RU - Federazione Russa 1.987
PL - Polonia 1.617
HK - Hong Kong 761
SE - Svezia 736
IE - Irlanda 622
SG - Singapore 618
IT - Italia 568
CN - Cina 356
UA - Ucraina 291
DE - Germania 272
BR - Brasile 230
FI - Finlandia 179
GB - Regno Unito 166
JO - Giordania 115
IN - India 112
AU - Australia 102
FR - Francia 51
ID - Indonesia 43
VN - Vietnam 43
CI - Costa d'Avorio 35
BE - Belgio 34
CH - Svizzera 34
TR - Turchia 32
AT - Austria 27
CA - Canada 25
ES - Italia 21
NL - Olanda 20
SC - Seychelles 12
AR - Argentina 7
UZ - Uzbekistan 7
BD - Bangladesh 6
EU - Europa 6
LV - Lettonia 6
KR - Corea 5
MX - Messico 5
NO - Norvegia 5
RO - Romania 5
CZ - Repubblica Ceca 4
IQ - Iraq 4
AL - Albania 3
CO - Colombia 3
PE - Perù 3
PH - Filippine 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
GE - Georgia 2
PK - Pakistan 2
PY - Paraguay 2
RS - Serbia 2
TN - Tunisia 2
TW - Taiwan 2
ZA - Sudafrica 2
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
HU - Ungheria 1
JM - Giamaica 1
JP - Giappone 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
SN - Senegal 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 19.044
Città #
Santa Clara 2.436
Warsaw 1.613
Fairfield 969
Chandler 799
Hong Kong 631
Dublin 621
Ashburn 520
Jacksonville 508
Woodbridge 474
Seattle 414
Cambridge 382
Houston 363
Singapore 345
Wilmington 326
Ann Arbor 282
Princeton 175
Florence 163
Buffalo 120
Lawrence 113
Altamura 111
Boardman 109
Boston 101
Melbourne 100
Beijing 94
Medford 84
Shanghai 79
Mumbai 77
Moscow 60
San Diego 56
Munich 48
New York 43
Jakarta 41
Los Angeles 40
Abidjan 35
Brussels 34
Bern 32
Turku 32
Dong Ket 30
Milan 28
The Dalles 28
Vienna 27
Norwalk 26
Paris 24
West Jordan 22
Izmir 21
Barcelona 20
Kent 20
Yubileyny 20
Falls Church 17
Hillsboro 16
Toronto 16
Salerno 15
Frankfurt Am Main 12
São Paulo 12
Andover 11
Bengaluru 11
Phoenix 11
Verona 11
Auburn Hills 10
Rome 10
Brooklyn 9
Helsinki 9
London 9
Redmond 9
Bremen 8
Chicago 8
Hefei 8
Pune 8
Zhengzhou 8
Amsterdam 7
Falkenstein 7
Ankara 6
Bari 6
Guangzhou 6
Laurel 6
Riga 6
Shenzhen 6
Stockholm 6
Tashkent 6
Belo Horizonte 5
Catania 5
Charlotte 5
Fiesole 5
Hangzhou 5
Palermo 5
Rio de Janeiro 5
San Mateo 5
Bologna 4
Brasília 4
Caruaru 4
Grafing 4
New Delhi 4
Old Bridge 4
Olomouc 4
Oslo 4
Padova 4
Prato 4
Salt Lake City 4
San Francisco 4
Santo André 4
Totale 13.078
Nome #
Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: deregulation in systemic sclerosis 305
GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides 303
Chronic resveratrol treatment inhibits MRC5 fibroblast SASP-related pro-tumoral effects on melanoma cells 300
u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression 279
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells 271
Th1-induced CD106 expression mediates leukocytes adhesion on synovial fibroblasts from juvenile idiopathic arthritis patients 257
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). 251
Type II CRISPR/Cas9 approach in the oncological therapy 249
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis. 241
A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients. 233
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells 227
Oleuropein aglycone attenuates the pro-angiogenic phenotype of senescent fibroblasts: a functional study in endothelial cells 211
Correction: Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: Deregulation in Systemic sclerosis (PLoS ONE (2013) 8, 7, (e68117) doi: 10.1371/journal.pone.0068117) 205
Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme 192
Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis. 183
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style. 178
Urokinase and its receptor in follicular and inflammatory cysts of the jaws. 174
Tumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A "cellular stove" approach to the photoablation of melanoma 172
Endothelial Progenitor Cells as Shuttle of Anticancer Agents 167
Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1 164
Fabrication of GM3-enriched sphingomyelin/cholesterol solid-supported lipid membranes on Au/SiO2 plasmonic substrates. 163
Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae. 162
Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: The amoeboid angiogenesis 159
FGF2-mediated upregulation of urokinase-type plasminogen activator expression requires a MAP-Kinase dependent activation of poly(ADP-Ribose) polymerase 158
Transforming growth factor beta-1 stimulates invasivity of hepatic stellate cells by engagement of the cell-associated fibrinolytic system. 156
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases. 155
The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation. 154
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells 153
Intercellular glycosaminoglycans in human cancer 151
Chronic resveratrol treatment reduces the pro-angiogenic effect of human fibroblast "Senescent Associated Secretory Phenotype" (SASP) on endothelial colony forming cells: the role of IL8 151
CELL SURFACE GLYCOSAMINOGLYCANS IN NORMAL END LEUKEMIC LEUKOCYTES. 149
Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor. 143
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium 143
Endothelial Progenitor Cells in Sprouting Angiogenesis: Proteases Pave the Way. 141
Surface glycosaminoglycans and calcium distribution in 3T3 cells. 140
Cell invasion is affected by differential expression of the urokinase plasminogen activator/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients. 140
Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes. 139
Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential. 139
The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis. 139
Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system. 137
Sulphated polysaccharides and the differentiation of the cellular slime mould Dictyostelium discoideum 137
ELECTROPHORETIC CHARACTERIZATION OF SURFACE HEPARAN SULPHATES IN NORMAL AND VIRUS TRANSFORMED 3T3 CELLS. 136
Plasminogen activator: morphological evidence of binding, internalization and delivery to lysosomes in 3T3 mouse fibroblasts. 133
Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis 132
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 130
Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. 129
Brn-3a, a neuronal transcription factor of the POU gene family: indications for its involvement in cancer and angiogenesis. 129
Cell surface glycosaminoglycans in normal and leukemic leukocytes. 129
Proteomic identification of VEGF-dependent protein enrichment to membrane caveolar-raft microdomains in endothelial progenitor cells. 129
Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12 128
TGFb1 antagonistic peptides inhibit TGFb1-dependent angiogenesis 128
Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis. 127
PRODUCTION OF SECOND MESSENGERS FOLLOWING CHEMOTACTIC AND MITOGENIC UROKINASE-RECEPTOR INTERACTION IN HUMAN FIBROBLASTS AND MOUSE FIBROBLASTS TRANSFECTED WITH HUMAN UROKINASE RECEPTOR. 126
Endothelial sphingosine kinase/SPNS2 axis has a critical role in migration and vessel-like formation of human mesoangioblasts 126
Modulation of surface-associated urokinase in different cell lines: evidence for urokinase interiorization and degradation. 125
Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma 125
Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes. 124
Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. 124
Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters 124
Modulation of surface-associated urokinase in different cell lines: evidence for urokinase interiorization and degradation. 124
The β-subunit of cholera toxin has a high affinity for ganglioside GM1 embedded into solid supported lipid membranes with a lipid raft-like composition. 122
Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth. 121
Plasminogen activators and inhibitor type-1 in alveolar osteitis. 121
I GLICOSAMINOGLICANI NELL'ADESIONE DEI LEUCOCITI POLIMORFONUCLEATI E DELLE PIASTRINE. 120
Adhesion-dependent heparin production by platelets. 120
Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice. 120
Glycosaminoglycan changes involved in polymorphonuclear leukocyte activation in vitro. 119
Modulation of urokinase receptors on human synovial cells and osteoarthritic chondrocytes by diacetylrhein 119
uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells 119
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes. 119
Poly(ADP-ribosyl)ation, a molecular switch of transcription, shows an attractive relationship with urokinase expression 118
Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a CTGF(CCN2)/TGF-beta-dependent mesechymal-to mesenchymal transition 118
Cell surface glycosaminoglycans in normal and leukemic leukocytes. 118
Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells 117
Reduction of in vitro invasion and in vivo cartilage degradation in a SCID mouse model by loss of function of the fibrinolytic system of rheumatoid arthritis synovial fibroblasts. 117
Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor. 116
Modulation of surface-associated urokinase: binding, interiorization, delivery to lysosomes, and degradation in human keratinocytes 116
Inhibition of spontaneous growth and induced differentiation of murine erythroleukaemia cells by paraquat and atrazine. 116
Interaction of urokinase with specific receptors abolishes the time of commitment to terminal differentiation of murine erythroleukaemia (Friend) cells. 115
Urokinase-type plasminogen activator is the main plasminogen activator produced by synoviocytes of osteoarthritis and rheumatoid arthitis 115
Endothelial cells and normal breast epithelial cells empower invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression. 114
Cooperative effect of exogenous heparin-like compounds and secreted glucocorticoid-induced inhibitor on plasminogen activator in 3T3 cell cultures. 114
Interaction of urokinase A-chain with the cellular receptor induces both urokinase autocriny and cell movement. 113
Regulation of urokinase/urokinase receptor interaction by heparin-like glycosaminoglycans. 112
Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential. 111
FGF-2 EFFECT ON POLY(ADP-RIBOSE) POLYMERASE ACTIVITY IN TRANSFORMED BOVINE ENDOTHELIAL CELLS 110
Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation 109
The Mr 17500 region of the A chain of urokinase is required for interaction with a specific receptor in A431 cells. 109
Selective localization of receptors for urokinase amino-terminal fragment at substratum contact sites of an in vitro-established line of human epidermal cells. 109
Antimessenger oligonucleotide for urokinase receptor gene inhibits invasivity of transformed human fibroblasts 107
The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein. 107
Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface. 106
Gold labeling of urokinase plasminogen activator. Characterization and specific binding in cultured mammalian cells. 106
Receptors for plasminogen activators, urokinase, in normal and Rous Sarcoma Virus-transformed mouse fibroblasts 103
The plasminogen activation system in inflammation. 102
Proteases and extracellular environment. 101
Bone Morphogenetic Protein-14 Regulates TGF-β-Dependent Angiogenesis in Breast Carcinoma MCF-7 Cells: In Vitro and in Vivo Control by Anti-TGF-β Peptides 100
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines 100
Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling 98
Cell-mediated release of nanoparticles as a preferential option for future treatment of melanoma 98
Totale 14.594
Categoria #
all - tutte 52.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202051 0 0 0 0 0 0 0 0 0 0 0 51
2020/20211.998 144 160 145 205 89 254 76 170 162 317 118 158
2021/20221.107 35 104 46 57 47 51 36 78 60 50 254 289
2022/20232.987 302 463 143 251 263 527 377 207 325 11 67 51
2023/20241.037 37 131 156 46 71 138 40 267 13 60 46 32
2024/20257.116 265 737 437 1.100 2.169 939 89 453 288 162 300 177
Totale 19.248